168 related articles for article (PubMed ID: 37414929)
21. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
[TBL] [Abstract][Full Text] [Related]
22. Lipoxin A
Zhang T; Hao H; Zhou ZQ; Zeng T; Zhang JM; Zhou XY
Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106380. PubMed ID: 31698141
[TBL] [Abstract][Full Text] [Related]
23. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
24. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
[TBL] [Abstract][Full Text] [Related]
25. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
[TBL] [Abstract][Full Text] [Related]
26. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
27. Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors.
Tu K; Li J; Verma VK; Liu C; Billadeau DD; Lamprecht G; Xiang X; Guo L; Dhanasekaran R; Roberts LR; Shah VH; Kang N
Hepatology; 2015 Jan; 61(1):361-74. PubMed ID: 24917558
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling.
Zhou B; Zeng S; Li L; Fan Z; Tian W; Li M; Xu H; Wu X; Fang M; Xu Y
Biochim Biophys Acta; 2016 Jun; 1862(6):1203-13. PubMed ID: 26850475
[TBL] [Abstract][Full Text] [Related]
29. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.
Carson JP; Robinson MW; Ramm GA; Gobert GN
Mol Biol Rep; 2021 Dec; 48(12):7677-7688. PubMed ID: 34648138
[TBL] [Abstract][Full Text] [Related]
30. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
31. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
Hu YB; Ye XT; Zhou QQ; Fu RQ
Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
[TBL] [Abstract][Full Text] [Related]
32. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
He C; Shu B; Zhou Y; Zhang R; Yang X
Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
[TBL] [Abstract][Full Text] [Related]
33. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
36. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway.
Yaqoob U; Luo F; Greuter T; Jalan Sakrikar N; Sehrawat TS; Lu J; Hu X; Gao J; Kostallari E; Chen J; Arab JP; Martin-Mateos R; Cao S; Shah VH
Cell Mol Gastroenterol Hepatol; 2020; 10(3):545-559. PubMed ID: 32447051
[TBL] [Abstract][Full Text] [Related]
37. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
38. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis.
Chen X; Li WX; Chen Y; Li XF; Li HD; Huang HM; Bu FT; Pan XY; Yang Y; Huang C; Meng XM; Li J
Cell Death Dis; 2018 Oct; 9(10):1021. PubMed ID: 30282980
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis.
Tao L; Xue D; Shen D; Ma W; Zhang J; Wang X; Zhang W; Wu L; Pan K; Yang Y; Nwosu ZC; Dooley S; Seki E; Liu C
Arch Toxicol; 2018 Sep; 92(9):2935-2946. PubMed ID: 30097701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
